Incyte climbs on combo data for IDO inhibitor epacadostat | Fierce Biotech
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study | Journal for ImmunoTherapy of Cancer
INCB24360 (epacadostat) – All About Drugs
IDO to I DON'T – IDO1 Inhibitor Development News
Beyond PD-1 Immunotherapy in Malignant Melanoma | SpringerLink
aacrindoximod
Biomedicines | Free Full-Text | Cancer Vaccines in Ovarian Cancer: How Can We Improve? | HTML
Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities: Trends in Pharmacological Sciences
Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'. - Abstract - Europe PMC
IDO Is Still A Valid Pathway For NewLink Genetics (NASDAQ:LUMO) | Seeking Alpha
Epacadostat - Wikipedia
Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1 | Aging
The State of IDO Inhibitor Combinations in the Treatment of Melanoma
INCB24360 (epacadostat) – All About Drugs
Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase** - Ortiz‐Meoz - 2021 - ChemBioChem - Wiley Online Library
Indoximod - an overview | ScienceDirect Topics
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry - MedChemComm (RSC Publishing) DOI:10.1039/C7MD00109F
JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update | HTML
AACR-NCI-EORTC B060 IDO1 Inhibitors - Oncolines B.V.
The therapeutic potential of targeting tryptophan catabolism in cancer | British Journal of Cancer
Epacadostat - Wikipedia
Frontiers | Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations | Molecular Biosciences
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy - ScienceDirect
Frontiers | Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers | Oncology
Epacadostat - an overview | ScienceDirect Topics
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab) | Business Wire
Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1 | Oncotarget
